Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

NCT05918055 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

NIH

Sponsor class

Stopped Drug company withdrew support.

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: KPT-8602
DRUG: Inqovi
PROCEDURE: Bone marrow aspirate
PROCEDURE: Bone marrow biopsy
DIAGNOSTIC_TEST: ECG

Sponsor

National Cancer Institute (NCI)